EUVIMEDEUVIMED entdecken
Crossref

Impact of Radiotherapy Dose on Local Control in Metastatic Ovarian Cancer: A Retrospective Analysis

Rosa Loimer, Alina Emiliana Sturdza, Stephan Polterauer, Thomas Bartl, Joachim Widder, Christoph Grimm, Maximilian Schmid, Johannes Knoth

Geburtshilfe und Frauenheilkunde · 16.11.2026

DOI: 10.1055/a-2984-3427 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 16.11.2026. Verfasst von Rosa Loimer und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Radiotherapy is a feasible treatment option in oligometastatic tumors including ovarian cancer. Evidence regarding a potential dose–response relationship remains limited. This study aimed to evaluate the association between radiation dose and treatment outcomes in metastatic ovarian cancer.

Methods

We retrospectively analyzed all patients with persistent or recurrent metastatic ovarian cancer treated with radiotherapy at our institution between August 2001 and July 2025. Lesion response was assessed according to RECIST version 1.1. The primary endpoint was the 6-month local control rate (LCR). Outcomes were analyzed according to clinicopathological parameters and dose stratification (cutoff: ≥ 39 Gy total dose or ≥ 5 Gy per fraction).

Results

In total, 71 patients comprising 107 irradiated lesions with a median clinical follow-up of 7.0 months (IQR 1.0–18.0) were included. Of these, 47 patients received high-dose radiotherapy and 24 received low-dose treatment. Higher radiation doses were associated with improved local control of treated lesions (6-month LCR of 96.1% vs. 86.8%; log-rank p = 0.003). Symptomatic response was assessable in 25 patients (35.2%), with improvement in 17 (68.0%), stability in 3 (12.0%) and deterioration in 5 (20.0%). Among all 32 subsequently treated patients (45.1%), the median time to next systemic therapy was 2.0 months (IQR 0.0–5.0). After radiotherapy, disease remained controlled in five patients (7.0%) each treated for a single lesion.

Conclusion

Higher radiation doses were associated with improved local control and may prolong the systemic treatment-free interval. Radiotherapy should be studied as part of multimodal treatment strategies in selected patients with metastatic ovarian cancer.

Zitieren

APA

Loimer, R., Sturdza, A. E., Polterauer, S., Bartl, T., Widder, J., Grimm, C., Schmid, M., & Knoth, J. (2026). Impact of Radiotherapy Dose on Local Control in Metastatic Ovarian Cancer: A Retrospective Analysis. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/a-2984-3427

Vancouver

Loimer R, Sturdza AE, Polterauer S, Bartl T, Widder J, Grimm C, et al. Impact of Radiotherapy Dose on Local Control in Metastatic Ovarian Cancer: A Retrospective Analysis. Geburtshilfe und Frauenheilkunde. 2026. doi:10.1055/a-2984-3427

BibTeX
@article{Loimer2026,
  author = {Loimer, Rosa and Sturdza, Alina Emiliana and Polterauer, Stephan and Bartl, Thomas and Widder, Joachim and Grimm, Christoph and Schmid, Maximilian and Knoth, Johannes},
  title = {Impact of Radiotherapy Dose on Local Control in Metastatic Ovarian Cancer: A Retrospective Analysis},
  journal = {Geburtshilfe und Frauenheilkunde},
  year = {2026},
  doi = {10.1055/a-2984-3427}
}
Kostenlos starten →